Stifel Financial’s Kindred Biosciences, Inc. KIN Stock Holding History

Stifel Financial’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-10,500	Closed	-$96K	–	3469
2021 Q2	$96K	Hold	10,500	–	–	﹤0.01%	3239
2021 Q1	$52K	Buy	+10,500	New	+$50.7K	﹤0.01%	3158

Other funds holding KIN

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Stifel Financial's KIN Position: Q3 2021 in Review

Stifel Financial sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 10,500 shares — an estimated $96K sold.

Stifel Financial first reported a position in KIN in Q1 2021 and held it in 2 quarters. The position peaked at $96K in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

Stifel Financial reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
Stifel Financial sold 10,500 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $96K.
Stifel Financial first reported a position in Kindred Biosciences, Inc. in Q1 2021 and held it in 2 quarters.
Stifel Financial's Kindred Biosciences, Inc. position peaked at $96K in Q2 2021.
1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Stifel Financial's 13F filing for Q3 2021, filed 15 Nov 2021.